Spirulina platensis inhibits anaphaylactic reaction

Life Sciences

Volumn 61, Issue 13, 1997, Pages 1237-1244

  Yang, Huh Nam ^a   Lee, Eun Hee ^a   Kim, Hyung Min ^a  

^a Wonkwang University   (South Korea)

Author keywords

Anaphylactic reactions; Histamine; Mast cells; Spirulina platensis

Indexed keywords

COMPOUND 48-80; HISTAMINE; PLANT EXTRACT; SPIRULINA PLATENSIS EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MAST CELL DEGRANULATION; MORTALITY; NONHUMAN; PERITONEUM MAST CELL; PHYTOTHERAPY; RAT;

ANIMALS; CELL DEGRANULATION; CYANOBACTERIA; DINITROPHENOLS; HISTAMINE; HISTAMINE RELEASE; IMMUNOGLOBULIN E; P-METHOXY-N-METHYLPHENETHYLAMINE; PASSIVE CUTANEOUS ANAPHYLAXIS; RATS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; SPIRULINA PLATENSIS;

EID: 0001026912     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00668-1     Document Type: Article

References (21)

1. S.I. WASSERMAN, and D.L. MARQUARDT, Anaphylaxis in Allergy: Principles and Practice. 3rd Ed., 1365, C. V. Mosby Co., St. Louis (1988).
2. L.J. PETERSEN, H. MOSBECH, and P. SKOV, J. Allergy Clin. Immunol. 97 672-679 (1996).
3. D. LAGUNOF, T.W. MARTIN, and G. READ, Annu. Rev. Pharmacol. Toxicol. 23 331-351 (1983).
4. M. ENNIS, F.L. PEARCE, and P.M. WESTON, Br. J. Phamacol. 70 329-334 (1980).
5. R. BALTZLY, J.S. BUCK, E.J. DE BEER, and F.S. WEBB, J. Am. Chem. Soc. 71 1301-1305 (1949).
6. W.D.M. PATON, Br. J. Phamacol. 6 499-508 (1951).
7. M.R. ALLANSMITH, R.S. BAIRD, R.N. ROSS, N.P. BARNEY, and K.J. BLOCH, Acta Ophthalmol. (Copenh) 67 145-153 (1989).
8. D.M. SEGAL, J TAUROG, and H. METZGER, Proc. Natl. Acad. Sci. USA 74 2993-2997 (1977).
9. H. METZGER, G. ALCARAZ, R. HOHMAN, J.P. KINET, V. PRIBLUDA, and R. QUARTO, Annu. Rev. Immunol. 4 419-470 (1986).
10. G. ALBER, L. MILLER, C. JELSEMA, N. VARTN-BLANK, and H. METZGER, J. Biol. Chem. 266 22613-22620 (1991).
11. H. SAITO, and Y. NOMURA, Screening methods for durg evaluation 3, In Pharmaceutical Research and Development, L. Suzuki, H. Tanaka, H. Yajima, H. Fukuda, H. Sezaki, K. Koga, M. Hirobe, and T. Nakajime (Eds), 22, Hirokawa, Tokyo (1989).
12. S. KATAYAMA, H. SHIONOYA, and S. OHTAKE, Microbiol. Immunol. 22 89-101 (1978)
13. P.A. SHORE, A. BURKHALTER, and V.H. COHN, J. Pharmacol. Exp. Ther. 127 182-186 (1959).
14. T.J. KANEMOTO, T. KASUGAI, A. YAMATODANI, H. USHIO, T. MOCHIZUKI, K. TOHYA, M. KIMURA, M. NISHIMURA, and Y. KITAMURA, Int. Arch. Allergy Immunol. 100 99-106(1993).
15. R.W. YURT, R.W. LEID, and K.F. AUSTEN, J. Biol. Chem. 252 518-521 (1977).
16. P. SCUDERI, R.E. STERLING, K.S. LAM, P.R. FINLEY, K.J. RYAN, C.G. RAY, E. PETERSEN, D.J. SLYMEN, and S.E. SALMON, Lancet 2 1364-1365 (1986).
17. B.K. WERSHIL, Y.A. MEKORI, T. MURAKAMI, and S.J. GALLI, J. Immunol. 139 2605-2614 (1987).
18. M.C. MOUSLI, C BRONNER, Y. LANDRY, J. BOCKAERT, and B. ROUOT, FEBS Lett. 259 260-262 (1990).
19. M.C. MOUSLI, C. BRONNER, J. BOCKAERT, B. ROUOT, and Y. LANDRY, Immunol. Lett. 25 355-358 (1990).
20. J.-L. BUEB, M.C. MOUSLI, C. BRONNER, B. ROUOT, and Y. LANDRY, Mol. Pharmacol. 38 816-822 (1990).
21. K. TASAKA, M. MIO, and M. OKAMOTO, Ann. Allergy 56 464-469 (1986).